European consensus on pre-operative imaging in breast cancer developed jointly by EUSOBI, ESSO, ESP and ESTRO

• by Julia Camps-Herrero, Roberto Lo Gullo, Alexandra Athanasiou, Michael Fuchsjaeger, Fiona J. Gilbert, Youlia Kirova, Christiane Kuhl, Ritse Mann, Francesco Meani, Federica Pediconi, Ruud Pijnappel, Cristina Saura, Tibor Tot, Katja Pinker

• June 16, 2026

ASCO26: Sara Tolaney, MD, MPH, ASCENT-03

Dana-Farber Cancer Institute's Dr. Sara Tolaney from the ASCENT-03 stud in breast cancer. The data further strengthens the case for approval of sacituzumab govitecan as first-line treatment for patients with advanced triple-negative breast cancer.

• July 1, 2026

• 1 min

Age, Age-Related Comorbidities and Survival in Palbociclib, Ribociclib and Abemaciclib Users With Advanced Breast Cancer: A Nation-Wide Retrospective Cohort Study

• by Blair Rajamaki, Olli Tenhunen, Liisa Pylkkänen, Thuan Vo, Anne Paakinaho, Miia Turpeinen, Sirpa Hartikainen, Anna-Maija Tolppanen

• July 1, 2026

Equity in Population-Wide Genomic Screening

• by Anne Mackie

• July 13, 2026